Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lilly, Stahl"'
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
T cell modulation in the clinical background of autoimmune diseases or allogeneic cell and organ transplantations with concurrent preservation of their natural immunological functions (e.g., pathogen defense) is the major obstacle in immunology. An a
Externí odkaz:
https://doaj.org/article/65911ece6b10487e9745c3b55a5ab3dd
Autor:
Sabine Kürzel, André‑René Blaudszun, Lilly Stahl, Regina Herbst, Frank Kroschinsky, Josef Birkmann, Annette Hänel, Kerstin Schaefer-Eckart, Gerhard Ehninger, Friedrich Fiedler, Martin Bornhäuser, Stephan Fricke, Mathias Hänel
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:929-931
Correction: Journal of Cancer Research and Clinical Oncology (2022) 148:1171-1181, https://doi.org/10.1007/s00432-021-03702-7
Autor:
Nadja Hilger, Claudia Mueller, Lilly Stahl, Anne M. Mueller, Bianca Zoennchen, Sarah Dluczek, Christoph Halbich, Claudia Wickenhauser, Dennis Gerloff, Alexander A. Wurm, Gerhard Behre, Anna Kretschmer, Stephan Fricke
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Despite the constant development of innovative therapeutic options for hematological malignancies, the gold-standard therapy regimen for curative treatment often includes allogeneic hematopoietic stem cell transplantation (HSCT). The graft-vs.-leukem
Externí odkaz:
https://doaj.org/article/175819f8293f47888a9b309e1d8f808f
Autor:
Josef Birkmann, André-René Blaudszun, Lilly Stahl, Sabine Kürzel, Regina Herbst, Frank Kroschinsky, Gerhard Ehninger, Mathias Hänel, Stephan Fricke, F. Fiedler, Kerstin Schaefer-Eckart, A. Hänel, Martin Bornhäuser
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:1171-1181
The aim of this study was to prospectively compare the MIFAP protocol, which had been shown to be effective in patients with relapsed and refractory Hodgkin’s lymphoma (HL) or aggressive non-Hodgkin’s lymphoma (NHL), to an established regimen lik
Autor:
Max, Hansen, Lilly, Stahl, Andreas, Heider, Nadja, Hilger, Ulrich, Sack, Andreas, Kirschner, Michael, Cross, Stephan, Fricke
Publikováno v:
Transplantation and cellular therapy. 27(8)
Graft-versus-host disease (GVHD) is one of the major complications following hematopoietic stem cell transplantation, which remains the sole curative therapy for many malignant diseases of the hematopoietic system. The immunomodulatory potential of m
Autor:
Lilly Stahl, Andreas Kirschner, Andreas Heider, Stephan Fricke, Ulrich Sack, Max Hansen, Michael Cross, Nadja Hilger
Publikováno v:
Transplantation and Cellular Therapy. 27:658.e1-658.e10
Graft-versus-host disease (GVHD) is one of the major complications following hematopoietic stem cell transplantation, which remains the sole curative therapy for many malignant diseases of the hematopoietic system. The immunomodulatory potential of m
Publikováno v:
Transfus med and hemother
Since the approval in 2017 and the outstanding success of Kymriah® and Yescarta®, the number of clinical trials investigating the safety and efficacy of chimeric antigen receptor-modified autologous T cells has been constantly rising. Currently, mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f25b19ac109cda677343b6a37f7444a4
https://publica.fraunhofer.de/handle/publica/256603
https://publica.fraunhofer.de/handle/publica/256603
Autor:
Lilly Stahl, Stephan Fricke, Claudia Müller, Anne M. Müller, Frank Emmrich, Jörg Lehmann, Ulla Schwertassek, Nadja Hilger, Christopher Oelkrug, Peter Ruschpler, Andreas Boldt, Jakob Glaser, Ulrich Sack, Franziska Lange, Christoph Halbich
Publikováno v:
Cytometry Part A. 89:803-815
NOD.Cg-Prkdc(scid) IL-2rg(tm1Wjl) /SzJ (NSG) mice are a valuable tool for studying Graft-versus-Host-Disease (GvHD) induced by human immune cells. We used a model of acute GvHD by transfer of human peripheral blood mononuclear cells (PBMCs) into NSG
Autor:
Lia, Walcher, Claudia, Müller, Nadja, Hilger, Anna, Kretschmer, Lilly, Stahl, Simone, Wigge, Jens, Rengelshausen, Anne M, Müller, Stephan, Fricke
Publikováno v:
Experimental Animals
Cyclosporine A (CsA) is used in hematopoietic stem cell transplantations (HSCT) to prevent graft-versus-host disease (GvHD). GvHD is the most severe side effect of allogeneic HSCT and efficient therapies are lacking. Mouse models are an essential too
Autor:
Nadja, Hilger, Jakob, Glaser, Claudia, Müller, Christoph, Halbich, Anne, Müller, Ulla, Schwertassek, Jörg, Lehmann, Peter, Ruschpler, Franziska, Lange, Andreas, Boldt, Lilly, Stahl, Ulrich, Sack, Christopher, Oelkrug, Frank, Emmrich, Stephan, Fricke
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology. 89(9)
NOD.Cg-Prkdc(scid) IL-2rg(tm1Wjl) /SzJ (NSG) mice are a valuable tool for studying Graft-versus-Host-Disease (GvHD) induced by human immune cells. We used a model of acute GvHD by transfer of human peripheral blood mononuclear cells (PBMCs) into NSG